GLP-1 medications (semaglutide and tirzepatide) are injected under the skin (subcutaneous), not into muscle Compounded GLP-1 medications come in multi-dose vials and require a syringe for accurate dosing Correct dosing is critical using a GLP-1 dose-to-units calculator helps prevent common mistakes The abdomen is the most commonly used injection site, but the thigh and upper arm are also safe options Rotate injection sites weekly to reduce irritation and improve medication absorption Always clean the injection site and remove air bubbles before injecting Never use medication that has been exposed to heat, sunlight, or freezing temperatures (especially important in Florida) Follow your healthcare providers instructions for dosing, storage, and injection technique GLP-1 medications are injectable treatments used for weight loss and metabolic support
IGF-1 inhibits MPTP/MPP(+)-induced autophagy on dopaminergic neurons through the IGF-1R/PI3K-Akt-mTOR pathway and GPER
It essentially slows down fat metabolism
[5] It has been hypothesized to act through GH-mediated pathways on the osteoblasts (bone-forming cells), possibly leading to increased proliferation, development, and differentiation of the osteoblasts
Post-cholecystectomy physiology changes bile acid regulation, which may affect gastrointestinal tolerance to GLP-1 agents and requires individualized evaluation
